Inpatient health care use among adult survivors of chronic childhood illnesses in the United States.
OBJECTIVE
To describe the inpatient length of stay and related charges for adults in the United States with childhood-onset chronic disease and to examine patterns with respect to different hospital settings.


METHODS
We analyzed data from the 2002 Nationwide Inpatient Sample, a nationally representative data set of hospital discharges. We performed a case-mix-adjusted, sample-weighted regression analysis as well as descriptive statistics of hospital use among adults with childhood-onset chronic disease.


METHODS
United States.


METHODS
We identified hospitalizations for persons aged 18 years or older with a diagnosis of complex congenital heart disease, cystic fibrosis, sickle cell disease, or spina bifida. Main Exposure Childhood chronic illness.


METHODS
Length of stay and total charges among pediatric, adult, and mixed hospitals.


RESULTS
In multivariate adjusted analyses, patients with complex congenital heart disease and cystic fibrosis had a significantly longer length of stay in pediatric hospitals than in adult or mixed hospitals (P<.001); no similar difference was found for sickle cell disease and spina bifida. For all of the 4 conditions, hospital charges were significantly greater in pediatric hospitals than in adult or mixed hospitals (P<.001 for cystic fibrosis, complex congenital heart disease, and sickle cell disease, and P<.01 for spina bifida).


CONCLUSIONS
The vast majority of persons who have survived to adulthood with complex congenital heart disease, cystic fibrosis, spina bifida, or sickle cell disease are hospitalized in hospitals that predominantly care for adults, where charges for care appear to be lower than in pediatric hospitals.
Okumura
Megumi J
MJ
Division of General Internal Medicine, Child Health Evaluation and Research Unit, University of Michigan, Ann Arbor, MI, USA. okumuram@peds.ucsf.edu
Campbell
Andrew D
AD
Nasr
Samya Z
SZ
Davis
Matthew M
MM
D000328:Adult; D000755:Anemia, Sickle Cell / Q000191:economics; D002648:Child; D002908:Chronic Disease / Q000191:economics*; D017281:Cost of Illness; D003550:Cystic Fibrosis / Q000191:economics; D005260:Female; D005500:Follow-Up Studies; D006330:Heart Defects, Congenital / Q000191:economics; D017722:Hospital Charges / Q000706:statistics & numerical data*; D006760:Hospitalization / Q000191:economics / Q000706:statistics & numerical data*; D006776:Hospitals, Pediatric / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D007902:Length of Stay / Q000191:economics; D008297:Male; D015999:Multivariate Analysis; D012044:Regression Analysis; D020379:Risk Adjustment; D016135:Spinal Dysraphism / Q000191:economics; D017741:Survivors / Q000706:statistics & numerical data*; D014481:United States